Health Open for ApplicationsPAR-25-210 Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
National Institutes of Health opportunity PAR-25-210
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
National Institutes of HealthPAR-25-210Grants.gov